Specific combinations of ligands (e.g. MIC-AB and ULBP-2 in our study, ULBP2 and ULBP4 in ovarian cancer [10]) do show additive effects or statistical interactions on prognostic value. This evidence concerns the gene RAET1E and ovarian cancer.